LEADING IN VITRO DIAGNOSTICS (IVD) COMPANIES RECENTLY REPORTED POSITIVE QUARTERLY FINANCIALS despite swirling concerns about trade tariffs and cuts to US federal research grants. It’s not yet clear what the long-term effect of tariffs’ will be on IVD manufacturers, assuming the trade fees remain in effect. Generally, executives are acknowledging the pressure but do not […]
Despite Trade Tariffs, IVD Firms Report Upbeat Earnings
For now, it appears diagnostic kit manufacturers are bearing tariffs and policy changes in China
- By Mark Terry
- > From the Volume XXXII, No. 12 - August 25, 2025 Issue
- Tags: Abbott Laboratories, BD, Beckman Coulter Diagnostics, Becton Dickenson and Company, Bio-Rad Laboratories, biopharma services, biotechnology, Cepheid, Chris DelOrefice, COVID-19, Danaher, diagnosis-related groups, DRG, genomics, Hologic, in vitro diagnostics, IVD companies, ivd/lab informatics, Joseph Busky, Leica, life sciences, Marc Casper, molecular diagnostics, next generation sequencing, Prahlad Singh, Qiagen, QuidelOrtho, Revvity, Robert Ford, Roche, Siemens Healthineers, Stephen Williamson, sysmex, tariffs, Thermo Fisher Scientific, Thierry Bernard, Thomas Schinecker PhD, Tom Polen, Waters
